Selling, general & administrative decreased 26.5%
Selling, general & administrative changed -26.5% from the comparable as-filed period.
$20.4M→$15.0M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →HNST financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure increased 840.7%
Capital expenditure changed +840.7% from the comparable as-filed period.
$81,000→$762,0003 prior comparisons
Revenue decreased 10.9%
Revenue changed -10.9% from the comparable as-filed period.
$93.5M→$83.3M2 prior comparisons
Cost of revenue decreased 22.9%
Cost of revenue changed -22.9% from the comparable as-filed period.
$55.7M→$42.9M2 prior comparisons
Free-cash-flow margin moved 3868 bp higher
Free-cash-flow margin changed +3868 basis points from the comparable as-filed period.
-0.88%→37.80%2 prior comparisons
Operating cash-flow margin moved 3951 bp higher
Operating cash-flow margin changed +3951 basis points from the comparable as-filed period.
-0.80%→38.71%2 prior comparisons
Total assets decreased 11.6%
Total assets changed -11.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$249.0M→$220.1M4 prior comparisons
Working capital decreased 10.7%
Working capital changed -10.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$167.7M→$149.8M4 prior comparisons
Current assets decreased 9.2%
Current assets changed -9.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$220.9M→$200.7M4 prior comparisons
Research & development decreased 12.1%
Research & development changed -12.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$2.0M→$1.7M2 prior comparisons
SBC / revenue moved 71 bp higher
SBC / revenue changed +71 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
2.91%→3.62%2 prior comparisons
Capex / revenue moved 83 bp higher
Capex / revenue changed +83 basis points from the comparable as-filed period.
0.09%→0.91%2 prior comparisons
Stock-based compensation increased 11.0%
Stock-based compensation changed +11.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$2.7M→$3.0M2 prior comparisons
Shares outstanding decreased 3.6%
Shares outstanding changed -3.6% from the comparable as-filed period. The change ranks at the 50th percentile of 8 prior comparable changes.
111,269,491→107,284,3798 prior comparisons
Current ratio decreased 5.0%
Current ratio changed -5.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
4.15→3.944 prior comparisons
Current liabilities decreased 4.4%
Current liabilities changed -4.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$53.3M→$50.9M4 prior comparisons
Working capital / assets moved 72 bp higher
Working capital / assets changed +72 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
67.32%→68.04%4 prior comparisons
Gross profit increased 6.9%
Gross profit changed +6.9% from the comparable as-filed period.
$37.8M→$40.4M2 prior comparisons
R&D / revenue moved 3 bp lower
R&D / revenue changed -3 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
2.10%→2.07%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.